DR. JOSEPH JAMES MERCHANT M.D. NPI 1699765826

NPI Details

DR. Joseph James Merchant, M.D. is a hematology and oncology internal medicine in Ames, IA with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Joseph James Merchant, M.D. NPI is 1699765826. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:1993

The provider's business location address is:

1111 DUFF AVE
AMES, IA
ZIP 50010-793
Phone: (515) 239-4401
Fax: (515) 239-4791

The NPI 1699765826 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Ferritin (blood protein) level (HCPCS:82728)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Protein measurement, serum (HCPCS:84165)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Total protein level, blood (HCPCS:84155)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Blood test, clotting time (HCPCS:85610)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Folic acid level, serum (HCPCS:82746)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Red blood cell concentration measurement (HCPCS:85014)
• Blood count, hemoglobin (HCPCS:85018)
• Unclassified drugs (HCPCS:J3490)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood count, automated test (HCPCS:85045)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell antibody detection test, direct (HCPCS:86880)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Liver function blood test panel (HCPCS:80076)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Uric acid level, blood (HCPCS:84550)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Bacterial colony count, urine (HCPCS:87086)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Blood creatinine level (HCPCS:82565)
• Declotting of central venous tube (HCPCS:36593)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)

The enumeration date for this NPI number is 10/27/2005 and was last updated on 11/16/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.